InvestorsHub Logo
Followers 60
Posts 8314
Boards Moderated 1
Alias Born 10/30/2015

Re: None

Wednesday, 11/25/2015 11:27:29 PM

Wednesday, November 25, 2015 11:27:29 PM

Post# of 106841
The ultra low volume will kill this company.

Liquidity to buy and sell Bioheart' stock is so low at a measly few thousand shares, it's unlikely that they will be able to raise even the most toxic dilutive financing. Even buying shares at a steep discount isn't worth anything if the toxic financier can't sell those shares back to uninformed investors.